Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous concentrated bone marrow transplantation for idiopathic osteonecrosis of the femoral head
jRCTc032200027Completed
- Start
- May 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous concentrated bone marrow in idiopathic osteonecrosis of the femoral head (ONFH). Primary endpoint: Safety. Started May 2020; status: completed.
02
Drugs
autologous concentrated bone marrow
03
Conditions
idiopathic osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on jRCTc032200027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTc032200027.